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Abstract
Background: Placenta accreta spectrum is one of the most serious complications of placenta
previa and is frequently associated with severe obstetric hemorrhage usually necessitating
hysterectomy. The management of placenta accrete spectrum will be discussed here and is
essentially the same. The following discussion of management of placenta accreta spectrum
applies to all depths of placental invasion. Incidence: In 1950 placentaaccreta was rare,
occurring 1 in 30.000 deliveries in the United States. Duringbetween 2008 and 2011 in a
cohort of over 115.000 deliveries in 25 hospitals in the United States reaching 1 in 731
deliveries. The marked increase has been attributed to the increasing prevalence of cesarean
delivery in recent decades.The incidence of placenta accreta spectrum will also increase due
to increasing of caesarean section rate. Case: Mrs.44 yo, G3P2 36-37weekslive, previous
cesarean section 2 time,placenta previa totalis, placenta percreta. She’s comes with a chief
complaint of lower abdominal cramps, patients regularly antenatal care at obstetrician.
Ultrasound finding, a single fetus lives at transvers lie, dorso superior, corresponding to 36-
37 weeks, placenta previa, placenta percreta (PAI:83%). This patient planned for elective
conservative surgery management, due to cesarean section and or cesarean hysterectomy.
Discussion:Surgical conservative management giving birth a baby without a placenta,
followed by a hysterectomy, has been shown to reduce the risk of bleeding and the need for
blood transfusion. The discovery of placenta accreta spectrum earlier when antenatal care,
better birth planning than multidisciplinary science includedfetomaternal, gyneco-oncologist,
anesthesiologist, thorac& cardiovascular surgeon, radiology intervention, intensivist -
obstetric intensive care, urologist and neonatology can determine the success of handling
cases of placenta accreta spectrum so as to reduce maternal, fetal morbidity and mortality.
Conclusions: The discovery of placenta accreta spectrum earlier when antenatal care,
planning delivery is better than multidisciplinary science. Management with corporal
incisions away from placental implantation, giving birth baby without a placenta, followed by
a hysterectomy, has been shown to reduce the risk of bleeding and the need for blood
transfusion.
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Manajemen Placenta Percreta dengan  Hysterectomy Total Abdominal : Study Kasus
Abstrak
Latar Belakang: Spektrum plasenta akreta adalah salah satu komplikasi plasenta previa yang
paling serius dan sering dikaitkan dengan perdarahan obstetrik parah yang biasanya
memerlukan histerektomi. Pengelolaan spektrum akresi plasenta akan dibahas di sini dan
pada dasarnya sama. Pembahasan manajemen spektrum plasenta akreta berikut ini berlaku
untuk semua kedalaman invasi plasenta. Insidensi: Pada tahun 1950 plasentaaccreta jarang
terjadi, terjadi 1 dari 30.000 pengiriman di Amerika Serikat. Selama antara 2008 dan 2011
dalam kelompok lebih dari 115.000 pengiriman di 25 rumah sakit di Amerika Serikat
mencapai 1 dari 731 pengiriman. Peningkatan yang ditandai telah dikaitkan dengan
meningkatnya prevalensi kelahiran sesar dalam beberapa dekade terakhir. Insiden spektrum
plasenta akreta juga akan meningkat karena peningkatan tingkat operasi caesar. Kasus:
Mrs.44 yo, G3P2 36-37weekslive, sebelumnya seksio sesarea 2 kali, plasenta previa totalis,
plasenta percreta. Dia datang dengan keluhan utama kram perut bagian bawah, pasien secara
teratur melakukan pemeriksaan kehamilan di dokter kandungan. Temuan USG, janin tunggal
hidup di transvers kebohongan, lebih tinggi, sesuai dengan 36-37 minggu, plasenta previa,
plasenta percreta (PAI: 83%). Pasien ini merencanakan untuk manajemen operasi konservatif
elektif, karena operasi caesar dan atau operasi caesar. Diskusi:Manajemen konservatif bedah
melahirkan bayi tanpa plasenta, diikuti dengan histerektomi, telah terbukti mengurangi risiko
perdarahan dan kebutuhan transfusi darah. Penemuan spektrum plasenta akreta lebih awal
ketika perawatan antenatal, perencanaan kelahiran yang lebih baik daripada ilmu
multidisiplin termasuk ibu, ginekolog, ahli anestesi, ahli bedah dada & kardiovaskular,
intervensi radiologi, intensivist - perawatan intensif obstetrik, urolog dan neonatologi dapat
menentukan keberhasilan penanganan kasus plasenta Spektrum akreta sehingga mengurangi
morbiditas dan mortalitas ibu, janin. Kesimpulan: Penemuan spektrum plasenta akreta lebih
awal ketika perawatan antenatal, merencanakan persalinan lebih baik daripada ilmu
multidisiplin. Manajemen dengan sayatan badan jauh dari implantasi plasenta, melahirkan
bayi tanpa plasenta, diikuti dengan histerektomi, telah terbukti mengurangi risiko perdarahan
dan kebutuhan untuk transfusi darah.
Kata kunci : plasenta previa, spektrum plasenta akreta, increta, percreta, dan adhesiva
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INTRODUCTION
Management of patients with placenta accreta spectrum (placenta accreta, increta, or
percreta) varies widely in the United States[1]. Although the impact of placenta accreta
spectrum on pregnancy outcomes is well described, no randomized trials and few studies
have examined the management of pregnancies complicated by this disorder. As a result,
recommendations for its management are based on case series and reports, personal
experience, expert opinion, and good clinical judgment. The management of placenta accreta,
increta, and percreta will be discussed here and is essentially the same, except when a
percreta extends to extrauterine tissue. Unless otherwise noted, the following discussion of
management of placenta accreta spectrum applies to all depths of placental invasion. The
clinical features and diagnosis of placenta accreta spectrum are reviewed separately[2].
Incidence placenta accreta is much more common than placenta increta and percreta. In a
pooled analysis of results from two series involving a total of 138 histologically confirmed,
abnormally implanted placentas from hysterectomy specimens, the types and frequencies of
abnormal placentation were[3,4]: Placenta accreta79%, Placenta increta14%, Placenta percreta
7%. In 1950, placenta accreta was rare, occurring in 1 in 30,000 deliveries in the United
States[5,7]. During the 1980s and 1990s, the incidence markedly increased, reaching 1 in 731
deliveries between 2008 and 2011 in a cohort of over 115,000 deliveries in 25 hospitals in the
US[5,6]. The marked increase has been attributed to the increasing prevalence of cesarean
delivery in recent decades[8].
Clinically, the placenta becomes a problem during labor when the placenta is not completely
separated from the uterus and is followed by massive obstetric hemorrhage, causing DIC,
hysterectomy, repair of ureteric, bladder, intestinal or neurovascular structures, adult
respiratory distress syndrome, transfusion reactions, electrolyte imbalance, and kidney
failure[10]. Maternal deaths with placenta percreta were reported to be as high as 20% and the
average perinatal mortality was 30%. Maternal death can occur despite optimal planning,
transfusion management, and surgical treatment. Placenta percreta causes 7% -10% of cases
of maternal death in the world[11].
Management by a multidisciplinary team and delivery in a tertiary care facility improve
outcomes and lower complication rates[17,18]. We schedule a multidisciplinary conference
with all the key care participants at least two weeks prior to planned delivery to ensure that
all necessary preparations are completed and management plans implemented[18].
The multidisciplinary team includes maternal-fetal medicine specialists, anesthesiologists,
neonatologists, interventional radiologists, and blood bank and nursing personnel. It is
desirable to have a surgeon in the operating room who has extensive experience with wide
dissection of the parametrium and exploration of the retroperitoneum in the event this
expertise is required for control of bleeding, bladder resection, and/or isolation, partial
resection, and/or reimplantation of the ureters. Some obstetrician gynecologists have this
experience, general surgeons, urologists, and vascular surgeons also have expertise in this
area. A urogynecologist, urologist, or gynecologic oncologist should be consulted in cases
where there is expected bladder involvement or if the surgeon does not have the requisite
surgical expertise[17].
If an appropriate multidisciplinary team and support services are not available at the site the
patient plans delivery, she should be transferred to a tertiary facility that has the capability to
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most effectively manage major intraoperative hemorrhage and provide postoperative
intensive care[17,18].
CASE REPORT
The 44-year-old woman claimed to be pregnant with her third child with a gestational age of
36-37 weeks. There was no previous history of abortion. Patients sent by obstetrician comes
with chief complaints of abdominal cramps from 1 day before admission to hospital,
contractions, blood slime and water broke was denied. The history of bloody and spotting at
the beginning of pregnancy is also denied by the patient. And patients still felt the fetal
movement until now. Patients antenatal care at the obstetrician 5 times and never to midwife,
the last control on August 6 2018 doctor said the fetal was good condition, but the placenta
covered the birth canal, doctors also say that the placenta is likely to penetrated to the uterine
muscle. So that the patient was planned for elective cesarean section on August 8, 2018. The
patient's history of vaginal discharge was recognized, but not itchy and odorless. Micturitions
and defecations was in normal limits. History of asthma bronchiale, hypertension, diabetes
mellitus, and heart disease in patients and families is denied. Based on history, patient's was
menarche at 12 years of age, regular cycle, with a period of 6-7 days without dysmenorrhea.
Birth history is 2 times with details: first child aged 15 years, male, birth weight 4800 g,
aterm, cesarean sections due to macrosomia at Meuraxa Hospital Banda Aceh, and the second
child was 13 years old, male, birth weight 4500 g, aterm, cesarean sections due to previous
cesarean sections 1 time, macrosomia at Harapan Bunda Hospital Banda Aceh. This is
currently the 3rd pregnant.
Physical examination was found that the general condition of the patient was good with
awareness of compos mentis, blood pressure 120/80 mmHg, pulse 80 x/minute, breathing 22
x/minute, temperature 36.6 C, BMI 25 kg/m2. Generalized status within normal limits.
Obstetric states in patients was obtained by fundal height 27 cm, head at left side, dorso
superior, no contraction,fetal heart rate 150 x/minute, genitalia inspection found vulva and
urethra within normal limits, inspeculo examination found smooth postio, ostium uteri closed,
negative fluxus, positive fluor albus, negative valsava and negative nitrazine test. vaginal
touché examination is not performed.
Blood count laboratory on August 7th 2018 obtained hemoglobin 11.1g/dl; hematocrit 33%;
leococyte 8.900ul/m3; platelets 322.000ul/m3; random blood glucous 106gr/dl; ALT 56mg/dl;
AST 48mg/dl; ureum 11mg/dl; creatinine 0.50mg/dl. The impression is within normal limits.
Cardiotocographic examination was obtained with reassuring of fetas state with a baseline of
145x/minute.
From the ultrasound examination on August 07th 2018, a single fetus, fetal heart rate positive,
transvers lie dorso superior. The implantation of placenta on the anterior corpus extends to
covered ostium uteri internum, maturation grade 1, lacunae appears grade 1, clear zone was
negative, bridging vessel positive, myometrial thickness 0.7mm, PAI score 6 correlated with
the possibility of placenta accrete 83%. Fetal biometry; BPD 95mm, HC 322.6mm, AC
338mm, FL 75mm, AFI 3cm single deepest pocket, estimated fetal weight 3538 gr.
Conclusion single fetus live transvers lie, head at live side, dorso superior ~ gestational age
36-37 weeks, placenta previa totalis, placenta percreta (PAI 8 = 83%).
1 2 3
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Figure 1 and 2Ultrasound examination showed the absence of a normal subplacentalsonolucent layer (clear zone) and lacuna positive
Figure 3. Abnormal blood vessels connecting from placenta to the serosa were seen on color Doppler imaging
Source : Photo intra operative medical record ZainoelAbidin Hospital Banda Aceh,  MR 1181009
Diagnosis of this patient is G3P2 36-37 wga singleton live transvers lie head on left side
dorso superior, previous caesarean section 2 time (interval delivery time 13 years), placenta
previa totalis, placenta percrete. In this patient, elective conservative surgical management is
planned, namely cesarean section to cesarean hysterectomy involving multidisciplinary
science on August 8th 2018 performed cesarean section with a corporal incision birth of
female baby with birth weight of 3500g, Apgar score 8/9, body length of 50cm, balard score
according to 38-40 weeks, the impression of term neonate appropriate for  gestational age.
Figure4. Severe adhesion between peritoneum with lower uterine segmen
Figure5. Placenta adhesive was invased until uterine serosa
Figure 6. Fetal cord and placenta invasion
Source :Photointra operativemedical recordZainoelAbidin Hospital Banda Aceh, MR 1181009
Intra operative shows that the placenta implants in the anterior corpus extends to cover of the
ostium uteri internum and there is obtained the placenta invades to the uterine serous layer
and there is no invasion from the placenta to the vesica urinaria or other intra-abdominal
organs. So it was decided to do a hysterectomy without giving birth to the placenta first. But
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Figure7. Placental invasion on uterine surface
Figure8. Uterus with plasentaintoto after evacuated
Source :Photo intra operative medical record ZainoelAbidin Hospital Banda Aceh,  MR 1181009
DISCUSSION
Placenta accreta spectrum should be suspected in women with placenta previa, especially
those implanted in the anterior corpus, and a history of cesarean or other uterine surgeries[3].
In these patients fetal ultrasound was found transvers lie with placenta previa totalis and
anterior implanted placenta, also obtained lacunae and bridging vessels with doppler
examination (PAI score 8) according to 83% probability. Based on anamnesis results,
physical examination and other investigations can be made diagnosed in these patients with
G3P2A0 36-37 wga transvers lie head at the left side dorso superior, previous caesarean
section 2 time, placenta previa totalis, placenta accreta. This patient management plan is
surgical conservative management with corporal incisions away from placental implantation,
giving birth to a baby without a placenta, followed by a hysterectomy, has been shown to
reduce the risk of bleeding and need for blood transfusion.
The discovery of placenta accreta spectrum earlier when antenatal care, planning delivery is
better than multidisciplinary science there is fetomaternal division, gynecology oncologist,
anesthesiologist, thorac& cardiovascular surgeon, radiology intervention, intensivis-obstetrics
intensive care, urologist and neonatology can determined the successfully of handling cases
of placenta accreta spectrum so as to reduced maternal, fetal morbidity and mortality[17].
The pathogenesis of morbidly placenta accreta spectrum includes defects in the fibrinoid
layer of nitabuch or in the decidua basalis caused by a variety of insults like excessive
curettage, infection or previous uterine surgery[29,30]. Pathophysiology also includes excessive
trophoblastic invasion[27,29]. Placenta previa is also a risk factor[6]. In our patient, placenta
previa and cesarean history 2 time is risk factor was observed, there might have been
excessive trophoblastic invasion. The increased rate of placenta percreta is due to the
increased cesarean section rate[28,29].
PRENATAL SCREENING FOR PLACENTA ACCRETA SPECTRUM DISORDERS
| Clinical screening |
Several risk factors for placenta accreta spectrum disorders have been identified. These
include advanced maternal age, multiparity, previous uterine surgery including curettage,
assisted reproductive techniques, and previous cesarean section[14].The most commonly
described risk factor is the combination of previous cesarean delivery and placenta
previa[15].This combination also poses other problems, including increased risk of prenatal
bleeding, access to the fetus for delivery, and the relatively poor contractility of the lower
segment leading to greater postpartum blood loss[16].
The prevalence of placenta accreta spectrum disorders in the general population of pregnant
women is around 1.7 per 10 000 pregnancies[14,15].However, the incidence of placenta
previaaccreta is 4.1% in women with one prior cesarean delivery and 13.3% in women with
two or more previous cesareans,and continues to rise with the number of prior
cesareans[14].Thus, focusing the screening of placenta accreta spectrum disorders on this
group is more productive in terms of diagnostic yield. All women found to have an anterior
low-lying (placental edge <2 cm from the internal cervical os after 16 weeks of gestation) or
placenta previa should be asked if they have had a previous cesarean delivery during prenatal
consultations and, if they do, they should be referred to a center with expertise in the prenatal
diagnosis of placenta accreta spectrumdisorders[14,15].
The management of placenta accreta spectrumincluded placenta accreta, increta, and
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percretawill be discussed here and is essentially the same, except when a percreta extends to
extrauterine tissue. Unless otherwise noted, the following discussion of management of
placenta accreta spectrum applies to all depths of placental invasion. The clinical features and
diagnosis of PAS are reviewed separately[2]. All patients with suspected placenta accrete
advantageous for low and middle income countries where expensive additional treatments
such as interventional radiology may not be available[40].
spectrum should be counseled about the diagnosis and potential sequelae (eg, hemorrhage,
blood transfusion, cesarean hysterectomy, maternal intensive care unit admission).
Consultation with a maternalfetal medicine specialist is desirable, and transfer to a center of
excellence for placenta accreta is strongly advised. For patients with placenta previaaccreta,
prenatal care follows typical guidelines for management of placenta previa. Nonstress tests
and/or biophysical profile scores are not performed routinely, but are used in pregnancies that
have standard indications for these tests (fetal growth restriction, preeclampsia,
oligohydramnios, and soon)[20].
A significant proportion of cases of placenta previa are associated with placenta accreta
spectrum disorders, particularly if the uterus is scarred and the placenta is anterior and/or
covering the cervix. Even if no villous tissue is invading the uterine myometrium, access to
the fetus is complicated by the position of the underlying placenta, the lower uterine segment
adjacent to the placenta is highly vascularized, and major hemorrhage can still occur. It
would be incorrect to believe that major morbidity should be expected only if prenatal
diagnosis of placenta accreta spectrum disorders has been made[14].
Source: The A Team, maternal fetal medicine div. Obstetric & Gynecology department Dr. Soetomo General Hospital, Universitas
Airlangga, Surabaya 2018
PROCEDURE
ALTERNATIVE CONSERVATIVE SURGICAL PROCEDURES
Algoritma Management PlasentaAcreta Spectrum
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| One-step conservative surgery |
This surgical procedure has been described primarily by one author[38].It consists of resecting
the invasive accreta area (partial myometrial resection) followed by immediate uterine
reconstruction and bladder reinforcement[39].This strategy aims to combine the advantages of
both the “leaving in situ approach” of preserving the uterus and cesarean hysterectomy with
minimal risk of secondary bleeding or infection. The main steps in this uterine sparing
technique can be performed via a modified Pfannenstiel or midline incision (Box 1).It is
Box 1 and 2 one step and stepwise conservative surgery  for Placenta accrete spectrum
Source: FIGO consensus guidelines on placenta accreta spectrum disorders: Conservative management,Int J Gynecology &Obstetry2018;
140: 291–298, doi:10.1002/ijgo.12410
In a cohort study of 68 women presenting with placental invasion of the adjacent organs
including invasion of the posterior upper bladder section (n=46; group 1) or of the posterior
lower vesical section (n=22; group 2), uterine preservation was achieved in 44 out of 46
(95.7%) and 6 out of 22 (27.3%) cases, respectively[3].The indications for the 18
hysterectomies were segmental circumferential rupture greater than 50% (n=13),
coagulopathy (n=2), infection (n=1), and uncontrolled hemodynamic instability (n=2).
Among the 50 women with uterine preservation, follow-up was available for 42 patients. A
normal menstrual cycle returned between 3 and 16 months. Ten women had another
uneventful pregnancy and delivery with no recurrence of placenta accrete spectrum
disorders[40].
| The Triple-P procedure |
A novel uterine-sparing procedure for placenta accrete spectrum disorders called the “Triple-
P procedure” was recently proposed[30,31].The aim of this procedure is to avoid incising
through the vascular placental venous sinuses, and to excise the myometrium with PAS
disorder tissue and to reconstitute the uterine defect. The main steps of this procedure
include: (1) perioperative placental ultrasound localization of the superior edge of the
placenta; (2) pelvic devascularization involving preoperative placement of intraarterial
balloon catheters (anterior division of the internal iliac arteries); and (3) no attempt to remove
the entire placenta with large myometrial excision and uterine repair. If the posterior wall of
the bladder is involved, the placental tissue invading the bladder is left in situ to avoid
cystotomy[15].
A comparison of two periods (i.e. before implementation of the Triple-P procedure (n=11)
and after (n=19)) showed no difference in the estimated mean blood loss and rate of
Box 1 One step conservative surgery approach
for placenta accreta spectrum (PAS) disorder.
Vascular disconnection of newly-formed (feeder) vessels
and the separation of invaded uterine tissues from
invaded vesical tissues.
Upper-segmental hysterotomy and delivery of the fetus.
Resection of all invaded myometrial tissue and the entire
placenta in one piece with previous local vascular
control.
Surgical procedures for hemostasis.
Myometrial reconstruction in two planes.
Bladder repair if necessary.
Box 2 Stepwise surgical approach for placenta accreta
spectrum (PAS) disorders.
Combined early intravenous uterotonics just before delivery of
the fetus.
Transverse ‘‘high’’ uterine incision at the upper border of the
placenta without cutting through the placenta.
Fetal delivery.
The uterus is exteriorized and compressed against the
symphysis pubis by assistant (transient bilateral kink of
uterine arteries).
Bilateral anterior division of internal iliac artery ligations.
Placental extraction (delayed after pelvic devascularization).
Proper identification of lower uterine segment by index and
ring fingers after identification of internal cervical os by
middle finger of left hand.
Repair of uterine incision.
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transfusion; however, the rates of postpartum hemorrhage and hysterectomy were lower in
the Triple-P procedure group[30].Larger studies are needed to demonstrate the safety and
efficacy of this technique[15].
| Cesarean Hysterectomy |
Preoperative ureteral stents may be placed, although they are of unproven efficacy. We make
a vertical skin incision or a Cherney incision and inspect the pelvis for signs of percreta and
the location of any collateral blood supply. An intraoperative ultrasound examination may be
done to map the placental edge and determine the best position for the hysterotomy incision.
We make a vertical hysterotomy at least two fingerbreadths above the placental edge; leaving
a myometrial margin between the placenta and incision helps to prevent disruption of the
placenta during opening or closing of the uterus[14].
After delivery of the infant, the cord is cut, the uterine incision is rapidly closed to decrease
blood loss, and hysterectomy is performed. We avoid internal iliac (hypogastric) artery
ligation because it is time consuming, operator dependent, ineffective (without hysterectomy)
for controlling pelvic hemorrhage in up to 60 percent of cases[32-33], and precludes use of
selective pelvic angiography and embolization if needed subsequently[15].
Management of placenta percreta with bladder invasion, placenta percreta with bladder
invasion may require partial cystectomy. In one review of 54 cases of placenta percreta
invading the bladder, partial cystectomy was performed in 24 of the 54 patients[32]. Ideally,
aurogynecologist, urologist, or gynecologic oncologist should be consulted when the bladder
is involved. Cystoscopy or intentional cystotomy at surgery is often helpful for assessing the
degree of bladder, and possible ureteral, involvement[33].
CONSERVATIVE PROCEDURES OF PLACENTA ACCRETA
Uterine conservation may be considered when the patient very much wants to preserve her
fertility. She should be counseled extensively regarding the risks of hemorrhage, infection,
possible need for intra or post operative life saving hysterectomy, and even death, as well as
suboptimal outcomes (including recurrence or hemorrhage) in future pregnancies. Uterine
conservation is also considered when hysterectomy is thought to have an unacceptably high
risk of hemorrhage or injury to other organs, which may be mitigated by leaving the placenta
in situ[18,22].
Uterine conservation with the placenta left in situ — In this approach, the placenta is left in
situafter delivery of the newborn and ligation of the cord at its placental insertion site. The
hysterotomy is closed in the standard way; uterotonic drugs, compression sutures, balloon
tamponade, uterine artery embolization, and/or uterine artery ligation are used, as needed, to
manage postpartum hemorrhage[34].
Adjunctive therapy with methotrexate therapy has been tried, with no convincing evidence
that it improves any outcome in these cases, and clear evidence of drug related harms
(pancytopenia, nephrotoxicity);it should not be used. Delayed hysteroscopic resection of
placental remnants has been used successfully to expedite resolution of the placenta or treat
delayed bleeding and/or pelvic pain, but experience is limited[35-36].
The immediate complications, as well as long term outcomes, of women who undergo uterine
conservation indicate that this approach should be attempted only rarely, in fully informed
patients, or as part of approved clinical trials. This is consistent with a Committee Opinion of
the American College of Obstetricians and Gynecologists[33].The prolonged course and
significant risks of uterine conservation with the placenta left in situ were illustrated by a
systematic review of 10 cohort studies and 50 case series or case reports describing 434
patients with placenta accreta, increta, or percreta managed conservatively (expectant
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management, uterine artery embolization, methotrexate therapy, hemostatic sutures, arterial
ligation, balloon tamponade)[37].
This approach is based on the following evidence-based clinical concepts[15]: (1)Cesarean
hysterectomy is considered the gold standard treatment for invasive accreta but it remains
associated with high rates (40%–50%) of severe maternal morbidity and, in cases of placenta
percreta, the mortality rates can be as high as 7% owing to damage to pelvic organs and
vasculature. (2) The extirpative method is associated with severe maternal morbidity because
it leaves, within the myometrium, placental tissues connected to large feeding vessels, which
are responsible for uncontrolled massive obstetric hemorrhage[40].
By leaving a placenta accreta in situ after the delivery of the fetus, one can expect a
progressive decrease in blood circulation within the uterus, parametrium, and the placenta.
This will result in secondary necrosis of the villous tissue and theoretically the placenta
should progressively detach itself from the uterus and the percreta villi from the adjacent
pelvic organs. Two separate surveys from the Society for Maternal Fetal Medicine
(SMFM)[14,15]reported that 14.9% of practitioners would attempt to leave the placenta in situ
in a hemodynamically stable patient and 32% had attempted conservative expectant
management for placenta accrete spectrum disorders. In an older survey on the preferences
for surgical versus conservative therapy in cases of placenta percreta, it was found that when
adjacent pelvic organs such as the bladder and bowel are involved, the majority of members
of the Society of Perinatal Obstetricians, with and without recent experience in the
management of placenta accrete spectrum disorders, opt for conservative management (69%
and 70%, respectively) compared with 31% when the accreta villous tissue is confined to the
uterus (percreta or increta)[37].
CONCLUSION
This patients reported with management of conservative surgery have a succesfullywith
corporal incisions away from placental implantation, giving birth to a baby without a
placenta, followed by a hysterectomy, has been shown to reduce the risk of bleeding and need
for blood transfusion.
Preoperative patient counseling should included discussion of the potential need for
hysterectomy, the risks of profuse hemorrhage, and possible maternal death.The
recommended management of suspected placenta accrete spectrum is planned preterm
cesarean hysterectomy with the placenta left in situ because removal of the placenta is
associated with significant hemorrhagic morbidity.
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